Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1996-12-6
|
pubmed:abstractText |
Stimulation of the airways of asthmatic individuals causes severe bronchoconstriction, which is in part neurally mediated via the vagus nerve. Local anesthetics are commonly administered to prevent this reflex-induced bronchoconstriction. Therefore, in a double-blind, placebo-controlled prospective study, we tested the effectiveness of oral mexiletine and intravenous lidocaine at blocking histamine-induced reflex bronchoconstriction. Fifteen subjects with mild asthma were selected (for whom the provocative concentration of histamine aerosol causing a 20% decrease in FEV1 (PC20) was less than 18 mg/ml). Subsequently, the subjects were pretreated with oral mexiletine, intravenous lidocaine, or placebo, and the histamine challenges were repeated. The baseline PC20 for histamine was 8.8 +/- 1.8 mg/ml. Mexiletine and lidocaine at therapeutic serum concentrations blocked reflex bronchoconstriction. Oral mexiletine increased the PC20 to 21.1 +/- 5.0 mg/ml (serum concentration: 0.7 +/- 0.05 microg/ml). Likewise, intravenous lidocaine increased the PC20 to 24.5 +/- 4.9 mg/ml (serum concentration: 2.6 +/- 0.15 microg/ml). Oral mexiletine and intravenous lidocaine block reflex-induced bronchoconstriction. Furthermore, mexiletine may have additional airway benefits when selected for the treatment of dysrhythmias or chronic pain in patients with coexisting lung diseases.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
154
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
885-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8887580-Adult,
pubmed-meshheading:8887580-Anesthetics, Local,
pubmed-meshheading:8887580-Asthma,
pubmed-meshheading:8887580-Bronchial Provocation Tests,
pubmed-meshheading:8887580-Bronchoconstriction,
pubmed-meshheading:8887580-Double-Blind Method,
pubmed-meshheading:8887580-Female,
pubmed-meshheading:8887580-Histamine,
pubmed-meshheading:8887580-Humans,
pubmed-meshheading:8887580-Lidocaine,
pubmed-meshheading:8887580-Male,
pubmed-meshheading:8887580-Mexiletine,
pubmed-meshheading:8887580-Premedication,
pubmed-meshheading:8887580-Prospective Studies,
pubmed-meshheading:8887580-Reflex,
pubmed-meshheading:8887580-Vagus Nerve
|
pubmed:year |
1996
|
pubmed:articleTitle |
Intravenous lidocaine and oral mexiletine block reflex bronchoconstriction in asthmatic subjects.
|
pubmed:affiliation |
Department of Anesthesiology and Environmental Health Services, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|